SIMONA ARNAUTOV: Open Payments
NPI 1003559428 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 39 payments from 18 companies in 2025. Trend: 2023 $1,177 · 2024 $1,180 · 2025 $978
Food & beverage: $879Education: $99
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $163 |
| Actelion Pharmaceuticals US, Inc. | 3 | $144 |
| Merck Sharp & Dohme LLC | 5 | $126 |
| PFIZER INC. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Medtronic, Inc. | 2 | $48 |
| Kestra Medical Technology Services, Inc. | 2 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| BridgeBio Pharma, Inc. | 1 | $32 |
Products named: JARDIANCE, OPSUMIT, VERQUVO, LEQVIO, ELIQUIS, Kerendia, VYNDAQEL, Assure WCD.
Industry payments across TX — which companies pay providers there.
